On September 17, Aehr Test rose 8.18% in regular trading, trading at $90.68 USD/share, with turnover of $127 million, rebounding sharply from recent lows hit during a broader semiconductor sector pullback.
The rally was driven by Oppenheimer initiating coverage on the company with an Outperform rating and a $120 price target. The firm highlighted that Aehr Test is positioned for an AI-driven inflection, as rising chip power and package value increases the cost of late-stage failures, making burn-in testing increasingly critical. Oppenheimer projected fiscal Q2 2027 revenue of $43.7 million, well above the $37 million consensus, and H1 revenue of $70.9 million versus the Street estimate of $63 million, citing strong Sonoma backlog.
Fundamental momentum further supported the move. The company secured a record $41 million order for its package-level burn-in platform Sonoma from a leading hyperscaler, while its wafer-level FOX-XP platform entered high-volume manufacturing with a major AI processor customer, including a $22 million follow-on order for systems to be shipped to Taiwan over six months. AI data center-related revenue is expected to account for approximately 70% of fiscal 2027 sales.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments